| 0 |
FMS-LIKE TYROSINE KINASE 3 POSITIVE |
1 |
0.2000 |
| 1 |
ADENOVIRAL ENCEPHALITIS |
1 |
0.0909 |
| 2 |
FLT3 GENE MUTATION |
1 |
0.0667 |
| 3 |
ORBITAL SPACE OCCUPYING LESION |
1 |
0.0625 |
| 4 |
TATTOO ASSOCIATED SKIN REACTION |
1 |
0.0435 |
| 5 |
MENINGOMYELITIS HERPES |
1 |
0.0312 |
| 6 |
VENIPUNCTURE |
1 |
0.0233 |
| 7 |
ELECTROCARDIOGRAM |
1 |
0.0164 |
| 8 |
PHLEBOTOMY |
1 |
0.0132 |
| 9 |
ADMINISTRATION SITE WARMTH |
1 |
0.0122 |
| 10 |
HEPATIC CYST INFECTION |
1 |
0.0102 |
| 11 |
VITH NERVE DISORDER |
1 |
0.0099 |
| 12 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
2 |
0.0096 |
| 13 |
VESSEL PUNCTURE SITE PAIN |
1 |
0.0094 |
| 14 |
DISSEMINATED TOXOPLASMOSIS |
1 |
0.0083 |
| 15 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
17 |
0.0079 |
| 16 |
ALLOGENIC STEM CELL TRANSPLANTATION |
1 |
0.0063 |
| 17 |
CATHETER SITE WARMTH |
1 |
0.0061 |
| 18 |
ELECTROCARDIOGRAM QT INTERVAL ABNORMAL |
3 |
0.0060 |
| 19 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
1 |
0.0058 |
| 20 |
DRUG RESISTANCE MUTATION |
1 |
0.0056 |
| 21 |
ACUTE MONOCYTIC LEUKAEMIA |
1 |
0.0055 |
| 22 |
MENINGOCOCCAL SEPSIS |
1 |
0.0053 |
| 23 |
MYOPERICARDITIS |
4 |
0.0051 |
| 24 |
RADIATION ASSOCIATED PAIN |
1 |
0.0048 |
| 25 |
TRANSPLANTATION COMPLICATION |
2 |
0.0048 |
| 26 |
CYTOMEGALOVIRUS GASTROENTERITIS |
1 |
0.0046 |
| 27 |
GASTRITIS BACTERIAL |
2 |
0.0043 |
| 28 |
ABSENCE OF IMMEDIATE TREATMENT RESPONSE |
1 |
0.0042 |
| 29 |
PERIPHERAL ARTERY STENOSIS |
2 |
0.0042 |
| 30 |
DIFFERENTIATION SYNDROME |
3 |
0.0041 |
| 31 |
ANORECTAL INFECTION |
1 |
0.0040 |
| 32 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
1 |
0.0035 |
| 33 |
ENGRAFT FAILURE |
1 |
0.0035 |
| 34 |
EAR INFLAMMATION |
1 |
0.0035 |
| 35 |
ENTEROBACTER BACTERAEMIA |
1 |
0.0033 |
| 36 |
ASPERGILLUS TEST POSITIVE |
1 |
0.0032 |
| 37 |
INCREASED DOSE ADMINISTERED |
1 |
0.0032 |
| 38 |
BLAST CELL COUNT INCREASED |
3 |
0.0029 |
| 39 |
GRAFT VERSUS HOST DISEASE IN SKIN |
6 |
0.0027 |
| 40 |
BONE MARROW DISORDER |
8 |
0.0026 |
| 41 |
BONE MARROW TRANSPLANT |
5 |
0.0026 |
| 42 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
1 |
0.0025 |
| 43 |
INFUSION |
1 |
0.0024 |
| 44 |
STEM CELL TRANSPLANT |
6 |
0.0024 |
| 45 |
CARDITIS |
1 |
0.0024 |
| 46 |
ARTERIAL STENOSIS |
2 |
0.0023 |
| 47 |
BIOPSY BONE MARROW |
1 |
0.0021 |
| 48 |
CENTRAL VENOUS CATHETER REMOVAL |
1 |
0.0021 |
| 49 |
ECZEMA ASTEATOTIC |
1 |
0.0021 |
| 50 |
DISSEMINATED ASPERGILLOSIS |
1 |
0.0021 |
| 51 |
NEUTROPENIC INFECTION |
2 |
0.0021 |
| 52 |
MINIMAL RESIDUAL DISEASE |
1 |
0.0021 |
| 53 |
MYELOID LEUKAEMIA |
1 |
0.0020 |
| 54 |
SYSTOLIC DYSFUNCTION |
2 |
0.0019 |
| 55 |
SEROSITIS |
1 |
0.0018 |
| 56 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
4 |
0.0017 |
| 57 |
ENGRAFTMENT SYNDROME |
1 |
0.0017 |
| 58 |
CHEMOTHERAPY |
6 |
0.0016 |
| 59 |
PLATELET TRANSFUSION |
2 |
0.0016 |
| 60 |
CARDIAC VENTRICULAR THROMBOSIS |
2 |
0.0015 |
| 61 |
VULVAL DISORDER |
1 |
0.0015 |
| 62 |
OESOPHAGITIS ULCERATIVE |
1 |
0.0015 |
| 63 |
FUSARIUM INFECTION |
1 |
0.0014 |
| 64 |
INTENSIVE CARE |
2 |
0.0014 |
| 65 |
GRAFT VERSUS HOST DISEASE IN LIVER |
1 |
0.0014 |
| 66 |
GRAFT VERSUS HOST DISEASE |
10 |
0.0014 |
| 67 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
2 |
0.0014 |
| 68 |
PARONYCHIA |
6 |
0.0014 |
| 69 |
CREATINE KINASE INCREASED |
1 |
0.0013 |
| 70 |
EXTRADURAL ABSCESS |
1 |
0.0013 |
| 71 |
TRANSPLANT |
3 |
0.0013 |
| 72 |
ENTEROCOCCAL SEPSIS |
1 |
0.0012 |
| 73 |
DENTAL DISCOMFORT |
1 |
0.0012 |
| 74 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
1 |
0.0012 |
| 75 |
LEUKAEMIA RECURRENT |
2 |
0.0012 |
| 76 |
THERAPY CHANGE |
11 |
0.0011 |
| 77 |
CEREBRAL TOXOPLASMOSIS |
1 |
0.0011 |
| 78 |
CATHETER SITE SWELLING |
1 |
0.0011 |
| 79 |
ACUTE MYELOID LEUKAEMIA |
16 |
0.0010 |
| 80 |
ELECTROCARDIOGRAM QT PROLONGED |
35 |
0.0010 |
| 81 |
RESPIRATORY TRACT IRRITATION |
1 |
0.0010 |
| 82 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 83 |
STREPTOCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 84 |
BRONCHOPULMONARY ASPERGILLOSIS |
7 |
0.0009 |
| 85 |
KLEBSIELLA SEPSIS |
1 |
0.0009 |
| 86 |
SYSTEMIC MYCOSIS |
1 |
0.0009 |
| 87 |
ESCHERICHIA BACTERAEMIA |
2 |
0.0008 |
| 88 |
FULL BLOOD COUNT DECREASED |
17 |
0.0008 |
| 89 |
TRANSPLANT FAILURE |
2 |
0.0008 |
| 90 |
PNEUMONIA FUNGAL |
3 |
0.0008 |
| 91 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
2 |
0.0007 |
| 92 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 93 |
CARDIAC FIBRILLATION |
1 |
0.0007 |
| 94 |
CENTRAL VENOUS CATHETERISATION |
2 |
0.0007 |
| 95 |
LEUKAEMIA |
6 |
0.0006 |
| 96 |
WHITE BLOOD CELL COUNT ABNORMAL |
4 |
0.0006 |
| 97 |
HAEMOGLOBIN ABNORMAL |
4 |
0.0006 |
| 98 |
GLYCOSYLATED HAEMOGLOBIN DECREASED |
1 |
0.0006 |
| 99 |
ACUTE LEUKAEMIA |
1 |
0.0006 |
| 100 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 101 |
IGA NEPHROPATHY |
1 |
0.0006 |
| 102 |
FEBRILE NEUTROPENIA |
39 |
0.0006 |
| 103 |
TREATMENT DELAYED |
1 |
0.0006 |
| 104 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0006 |
| 105 |
SKIN HYPOPIGMENTATION |
1 |
0.0006 |
| 106 |
NEUTROPENIC SEPSIS |
4 |
0.0006 |
| 107 |
MYELOSUPPRESSION |
20 |
0.0006 |
| 108 |
VULVOVAGINAL SWELLING |
1 |
0.0005 |
| 109 |
SOFT TISSUE INFECTION |
1 |
0.0005 |
| 110 |
CONTRAST MEDIA ALLERGY |
1 |
0.0005 |
| 111 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 112 |
NECROSIS |
3 |
0.0005 |
| 113 |
ANGIOPATHY |
3 |
0.0005 |
| 114 |
INTERVERTEBRAL DISCITIS |
1 |
0.0005 |
| 115 |
HUMAN HERPESVIRUS 6 INFECTION |
1 |
0.0005 |
| 116 |
ORAL INFECTION |
2 |
0.0005 |
| 117 |
HYPOGEUSIA |
1 |
0.0005 |
| 118 |
PLATELET COUNT ABNORMAL |
3 |
0.0005 |
| 119 |
CYTOPENIA |
6 |
0.0005 |
| 120 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
2 |
0.0005 |
| 121 |
CAPILLARY LEAK SYNDROME |
1 |
0.0005 |
| 122 |
LUNG ABSCESS |
1 |
0.0005 |
| 123 |
FULL BLOOD COUNT ABNORMAL |
5 |
0.0005 |
| 124 |
PLATELET COUNT DECREASED |
49 |
0.0005 |
| 125 |
LABORATORY TEST ABNORMAL |
13 |
0.0004 |
| 126 |
METHAEMOGLOBINAEMIA |
1 |
0.0004 |
| 127 |
UTERINE DISORDER |
1 |
0.0004 |
| 128 |
BACTERAEMIA |
5 |
0.0004 |
| 129 |
LONG QT SYNDROME |
1 |
0.0004 |
| 130 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 131 |
CORONARY ARTERY STENOSIS |
2 |
0.0004 |
| 132 |
VASODILATATION |
1 |
0.0004 |
| 133 |
PLATELET DISORDER |
1 |
0.0004 |
| 134 |
NO ADVERSE EVENT |
71 |
0.0004 |
| 135 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
1 |
0.0004 |
| 136 |
ELECTROCARDIOGRAM ABNORMAL |
3 |
0.0004 |
| 137 |
LUNG OPACITY |
1 |
0.0004 |
| 138 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 139 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 140 |
CHOLECYSTITIS INFECTIVE |
1 |
0.0004 |
| 141 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 142 |
ENTEROCOLITIS |
2 |
0.0003 |
| 143 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 144 |
ADRENAL INSUFFICIENCY |
4 |
0.0003 |
| 145 |
BLOOD CREATININE DECREASED |
1 |
0.0003 |
| 146 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 147 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 148 |
PLANTAR FASCIITIS |
1 |
0.0003 |
| 149 |
DISEASE PROGRESSION |
35 |
0.0003 |
| 150 |
CLOSTRIDIAL INFECTION |
1 |
0.0003 |
| 151 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 152 |
NEUTROPHIL COUNT DECREASED |
12 |
0.0003 |
| 153 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 154 |
LOCALISED INFECTION |
7 |
0.0003 |
| 155 |
HYPOPNOEA |
1 |
0.0003 |
| 156 |
BLOOD TEST ABNORMAL |
4 |
0.0003 |
| 157 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 158 |
AMYLASE INCREASED |
1 |
0.0003 |
| 159 |
CARDIOMYOPATHY |
4 |
0.0003 |
| 160 |
GASTRIC INFECTION |
1 |
0.0003 |
| 161 |
PERICARDIAL EFFUSION |
6 |
0.0003 |
| 162 |
TASTE DISORDER |
5 |
0.0002 |
| 163 |
INFECTION |
35 |
0.0002 |
| 164 |
CONGESTIVE CARDIOMYOPATHY |
1 |
0.0002 |
| 165 |
WHITE BLOOD CELL COUNT DECREASED |
25 |
0.0002 |
| 166 |
SEPTIC SHOCK |
10 |
0.0002 |
| 167 |
CARDIOTOXICITY |
2 |
0.0002 |
| 168 |
ORAL PAIN |
5 |
0.0002 |
| 169 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 170 |
SKIN LESION |
6 |
0.0002 |
| 171 |
DISEASE COMPLICATION |
1 |
0.0002 |
| 172 |
EAR DISORDER |
1 |
0.0002 |
| 173 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 174 |
PANCYTOPENIA |
12 |
0.0002 |
| 175 |
SKIN ABRASION |
1 |
0.0002 |
| 176 |
HAEMATOTOXICITY |
2 |
0.0002 |
| 177 |
CARDIAC TAMPONADE |
1 |
0.0002 |
| 178 |
RED BLOOD CELL COUNT DECREASED |
6 |
0.0002 |
| 179 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 180 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 181 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 182 |
LIVER DISORDER |
9 |
0.0002 |
| 183 |
VENOOCCLUSIVE LIVER DISEASE |
1 |
0.0002 |
| 184 |
ORGANISING PNEUMONIA |
1 |
0.0002 |
| 185 |
VEIN DISORDER |
1 |
0.0002 |
| 186 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 187 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 188 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 189 |
TRANSFUSION |
2 |
0.0002 |
| 190 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
3 |
0.0002 |
| 191 |
HEPATIC FUNCTION ABNORMAL |
7 |
0.0002 |
| 192 |
COMPRESSION FRACTURE |
1 |
0.0002 |
| 193 |
ANAL ABSCESS |
1 |
0.0002 |
| 194 |
STRESS FRACTURE |
1 |
0.0002 |
| 195 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 196 |
ASTHENOPIA |
1 |
0.0002 |
| 197 |
PULMONARY ALVEOLAR HAEMORRHAGE |
1 |
0.0002 |
| 198 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 199 |
MOUTH SWELLING |
1 |
0.0002 |
| 200 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 201 |
GANGRENE |
1 |
0.0002 |
| 202 |
PHOTOPSIA |
1 |
0.0002 |
| 203 |
HAEMOGLOBIN DECREASED |
16 |
0.0002 |
| 204 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 205 |
TOOTH INFECTION |
2 |
0.0002 |
| 206 |
VIRAL INFECTION |
5 |
0.0002 |
| 207 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 208 |
TERMINAL STATE |
1 |
0.0001 |
| 209 |
BODY TEMPERATURE INCREASED |
3 |
0.0001 |
| 210 |
DISSEMINATED INTRAVASCULAR COAGULATION |
2 |
0.0001 |
| 211 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 212 |
TONGUE DISORDER |
1 |
0.0001 |
| 213 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 214 |
INSURANCE ISSUE |
2 |
0.0001 |
| 215 |
LIPASE INCREASED |
1 |
0.0001 |
| 216 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 217 |
HAEMOLYSIS |
1 |
0.0001 |
| 218 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 219 |
BRAIN FOG |
2 |
0.0001 |
| 220 |
ILLNESS |
13 |
0.0001 |
| 221 |
THERAPY INTERRUPTED |
9 |
0.0001 |
| 222 |
PYREXIA |
43 |
0.0001 |
| 223 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 224 |
OSTEONECROSIS |
4 |
0.0001 |
| 225 |
CYTOMEGALOVIRUS INFECTION |
2 |
0.0001 |
| 226 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 227 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 228 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 229 |
MUSCLE STRAIN |
1 |
0.0001 |
| 230 |
ILL-DEFINED DISORDER |
7 |
0.0001 |
| 231 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 232 |
NEUROTOXICITY |
2 |
0.0001 |
| 233 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 234 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 235 |
PURPURA |
1 |
0.0001 |
| 236 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 237 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 238 |
LIP DRY |
1 |
0.0001 |
| 239 |
HYPERGLYCAEMIA |
4 |
0.0001 |
| 240 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 241 |
PRODUCT DOSE OMISSION ISSUE |
32 |
0.0001 |
| 242 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 243 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 244 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 245 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
3 |
0.0001 |
| 246 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 247 |
ATELECTASIS |
1 |
0.0001 |
| 248 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 249 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 250 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 251 |
BRAIN INJURY |
1 |
0.0001 |
| 252 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
0.0001 |
| 253 |
PLEURAL EFFUSION |
6 |
0.0001 |
| 254 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 255 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 256 |
SLUGGISHNESS |
1 |
0.0001 |
| 257 |
EMOTIONAL DISORDER |
3 |
0.0001 |
| 258 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 259 |
PRODUCT USE ISSUE |
18 |
0.0001 |
| 260 |
MOUTH ULCERATION |
2 |
0.0001 |
| 261 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 262 |
UNEVALUABLE EVENT |
7 |
0.0001 |
| 263 |
SKIN LACERATION |
1 |
0.0001 |
| 264 |
WOUND INFECTION |
1 |
0.0001 |
| 265 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
| 266 |
OFF LABEL USE |
79 |
0.0001 |
| 267 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 268 |
FUNGAL INFECTION |
3 |
0.0001 |
| 269 |
PNEUMONIA |
29 |
0.0001 |
| 270 |
SKIN INFECTION |
1 |
0.0001 |
| 271 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 272 |
NEUTROPENIA |
12 |
0.0001 |
| 273 |
MYOCARDITIS |
1 |
0.0001 |
| 274 |
TINNITUS |
4 |
0.0001 |
| 275 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 276 |
METASTASES TO LUNG |
1 |
0.0001 |
| 277 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 278 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 279 |
TENDON RUPTURE |
1 |
0.0001 |
| 280 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 281 |
ILEUS |
1 |
0.0001 |
| 282 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 283 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 284 |
MUCOSAL INFLAMMATION |
2 |
0.0001 |
| 285 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 286 |
DYSMENORRHOEA |
1 |
0.0001 |
| 287 |
BLOOD BILIRUBIN INCREASED |
2 |
0.0001 |
| 288 |
HEPATIC ENZYME INCREASED |
5 |
0.0001 |
| 289 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 290 |
DIVERTICULITIS |
2 |
0.0001 |
| 291 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 292 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 293 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 294 |
GASTROENTERITIS |
1 |
0.0001 |
| 295 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 296 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 297 |
CORONARY ARTERY DISEASE |
2 |
0.0001 |
| 298 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 299 |
DEATH |
56 |
0.0001 |
| 300 |
ANKLE FRACTURE |
1 |
0.0001 |
| 301 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 302 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 303 |
NAUSEA |
50 |
0.0001 |
| 304 |
DISEASE RECURRENCE |
3 |
0.0001 |
| 305 |
DRUG INTERACTION |
10 |
0.0001 |
| 306 |
LUNG DISORDER |
3 |
0.0001 |
| 307 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 308 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 309 |
HYPOXIA |
2 |
0.0001 |
| 310 |
DEPRESSED MOOD |
3 |
0.0001 |
| 311 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 312 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 313 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 314 |
GASTROINTESTINAL DISORDER |
5 |
0.0001 |
| 315 |
OSTEOMYELITIS |
1 |
0.0001 |
| 316 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 317 |
BONE DISORDER |
1 |
0.0001 |
| 318 |
THROMBOCYTOPENIA |
6 |
0.0001 |
| 319 |
EPISTAXIS |
4 |
0.0001 |
| 320 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 321 |
COLITIS |
2 |
0.0001 |
| 322 |
DYSPHAGIA |
5 |
0.0001 |
| 323 |
NEUROPATHY PERIPHERAL |
5 |
0.0001 |
| 324 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 325 |
INCREASED APPETITE |
1 |
0.0001 |
| 326 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 327 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 328 |
HERNIA |
1 |
0.0001 |
| 329 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 330 |
COVID-19 |
9 |
0.0001 |
| 331 |
ORAL HERPES |
1 |
0.0001 |
| 332 |
KIDNEY INFECTION |
1 |
0.0001 |
| 333 |
ASTHENIA |
19 |
0.0001 |
| 334 |
SINUS DISORDER |
1 |
0.0001 |
| 335 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 336 |
THERAPEUTIC RESPONSE DECREASED |
3 |
0.0000 |
| 337 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 338 |
STOMATITIS |
3 |
0.0000 |
| 339 |
FEEDING DISORDER |
1 |
0.0000 |
| 340 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 341 |
DERMATITIS |
1 |
0.0000 |
| 342 |
ABDOMINAL DISCOMFORT |
8 |
0.0000 |
| 343 |
FATIGUE |
37 |
0.0000 |
| 344 |
RETCHING |
1 |
0.0000 |
| 345 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 346 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 347 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 348 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 349 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 350 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 351 |
SEPSIS |
5 |
0.0000 |
| 352 |
VOMITING |
21 |
0.0000 |
| 353 |
SHOCK |
1 |
0.0000 |
| 354 |
HYPOKALAEMIA |
2 |
0.0000 |
| 355 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 356 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 357 |
RENAL DISORDER |
2 |
0.0000 |
| 358 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 359 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 360 |
INTERSTITIAL LUNG DISEASE |
2 |
0.0000 |
| 361 |
PRESYNCOPE |
1 |
0.0000 |
| 362 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 363 |
DYSPEPSIA |
4 |
0.0000 |
| 364 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 365 |
AGEUSIA |
1 |
0.0000 |
| 366 |
DRY EYE |
2 |
0.0000 |
| 367 |
HAEMATEMESIS |
1 |
0.0000 |
| 368 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 369 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 370 |
DIARRHOEA |
25 |
0.0000 |
| 371 |
PANCREATITIS |
2 |
0.0000 |
| 372 |
CARDIAC FAILURE |
3 |
0.0000 |
| 373 |
DRY MOUTH |
3 |
0.0000 |
| 374 |
CONSTIPATION |
8 |
0.0000 |
| 375 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 376 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 377 |
WOUND |
1 |
0.0000 |
| 378 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 379 |
PAIN IN JAW |
1 |
0.0000 |
| 380 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 381 |
ANGINA PECTORIS |
1 |
0.0000 |
| 382 |
HYPERSOMNIA |
1 |
0.0000 |
| 383 |
EYE IRRITATION |
2 |
0.0000 |
| 384 |
BALANCE DISORDER |
3 |
0.0000 |
| 385 |
DECREASED APPETITE |
8 |
0.0000 |
| 386 |
RASH |
15 |
0.0000 |
| 387 |
ASCITES |
1 |
0.0000 |
| 388 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 389 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
0.0000 |
| 390 |
APHASIA |
1 |
0.0000 |
| 391 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 392 |
EMOTIONAL DISTRESS |
4 |
0.0000 |
| 393 |
HOSPITALISATION |
5 |
0.0000 |
| 394 |
CARDIAC DISORDER |
3 |
0.0000 |
| 395 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 396 |
ANAEMIA |
6 |
0.0000 |
| 397 |
HIP FRACTURE |
1 |
0.0000 |
| 398 |
NIGHT SWEATS |
1 |
0.0000 |
| 399 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 400 |
ALOPECIA |
6 |
0.0000 |
| 401 |
EYE DISORDER |
1 |
0.0000 |
| 402 |
HEART RATE INCREASED |
3 |
0.0000 |
| 403 |
INSOMNIA |
8 |
0.0000 |
| 404 |
VISION BLURRED |
4 |
0.0000 |
| 405 |
BURNING SENSATION |
2 |
0.0000 |
| 406 |
HEART RATE DECREASED |
1 |
0.0000 |
| 407 |
MOBILITY DECREASED |
2 |
0.0000 |
| 408 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 409 |
RESTLESSNESS |
1 |
0.0000 |
| 410 |
AGITATION |
2 |
0.0000 |
| 411 |
NASOPHARYNGITIS |
5 |
0.0000 |
| 412 |
BRONCHITIS |
2 |
0.0000 |
| 413 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 414 |
THROMBOSIS |
2 |
0.0000 |
| 415 |
CARDIAC ARREST |
2 |
0.0000 |
| 416 |
POLLAKIURIA |
1 |
0.0000 |
| 417 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 418 |
HYPERTENSION |
5 |
0.0000 |
| 419 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 420 |
MYALGIA |
4 |
0.0000 |
| 421 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 422 |
HYPOACUSIS |
1 |
0.0000 |
| 423 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 424 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 425 |
TACHYCARDIA |
2 |
0.0000 |
| 426 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 427 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 428 |
DIZZINESS |
11 |
0.0000 |
| 429 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 430 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 431 |
ADVERSE EVENT |
2 |
0.0000 |
| 432 |
CHEST PAIN |
4 |
0.0000 |
| 433 |
ANXIETY |
6 |
0.0000 |
| 434 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 435 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 436 |
HYPOAESTHESIA |
3 |
0.0000 |
| 437 |
SYNCOPE |
2 |
0.0000 |
| 438 |
SOMNOLENCE |
4 |
0.0000 |
| 439 |
CELLULITIS |
1 |
0.0000 |
| 440 |
SINUSITIS |
2 |
0.0000 |
| 441 |
THERAPY CESSATION |
1 |
0.0000 |
| 442 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 443 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 444 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 445 |
HEADACHE |
12 |
0.0000 |
| 446 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 447 |
RASH PRURITIC |
1 |
0.0000 |
| 448 |
OEDEMA |
1 |
0.0000 |
| 449 |
ARTHROPATHY |
1 |
0.0000 |
| 450 |
INFLUENZA |
2 |
0.0000 |
| 451 |
URTICARIA |
3 |
0.0000 |
| 452 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 453 |
FLATULENCE |
1 |
0.0000 |
| 454 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 455 |
HERPES ZOSTER |
1 |
0.0000 |
| 456 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 457 |
BACK PAIN |
4 |
0.0000 |
| 458 |
PALPITATIONS |
2 |
0.0000 |
| 459 |
BONE PAIN |
1 |
0.0000 |
| 460 |
WHEEZING |
1 |
0.0000 |
| 461 |
FEELING HOT |
1 |
0.0000 |
| 462 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 463 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 464 |
SWELLING FACE |
1 |
0.0000 |
| 465 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 466 |
DRY SKIN |
2 |
0.0000 |
| 467 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 468 |
ERYTHEMA |
3 |
0.0000 |
| 469 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 470 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 471 |
ARTHRALGIA |
6 |
0.0000 |
| 472 |
COUGH |
4 |
0.0000 |
| 473 |
SLEEP DISORDER |
1 |
0.0000 |
| 474 |
UNDERDOSE |
1 |
0.0000 |
| 475 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 476 |
DYSGEUSIA |
1 |
0.0000 |
| 477 |
PAIN |
8 |
0.0000 |
| 478 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 479 |
PARAESTHESIA |
2 |
0.0000 |
| 480 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 481 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 482 |
DYSPNOEA |
7 |
0.0000 |
| 483 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 484 |
TREATMENT FAILURE |
1 |
0.0000 |
| 485 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 486 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 487 |
WEIGHT DECREASED |
3 |
0.0000 |
| 488 |
MIGRAINE |
1 |
0.0000 |
| 489 |
CONTUSION |
1 |
0.0000 |
| 490 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 491 |
HYPOTENSION |
2 |
0.0000 |
| 492 |
MALAISE |
4 |
0.0000 |
| 493 |
DRUG INEFFECTIVE |
12 |
0.0000 |
| 494 |
CHILLS |
1 |
0.0000 |
| 495 |
FEELING ABNORMAL |
2 |
0.0000 |
| 496 |
JOINT SWELLING |
1 |
0.0000 |
| 497 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 498 |
PRURITUS |
3 |
0.0000 |
| 499 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 500 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 501 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 502 |
FALL |
2 |
0.0000 |
| 503 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 504 |
MUSCLE SPASMS |
1 |
0.0000 |
| 505 |
WEIGHT INCREASED |
1 |
0.0000 |
| 506 |
DEPRESSION |
1 |
0.0000 |